Schroder Investment Management Group
IONS icon

Schroder Investment Management Group’s Ionis Pharmaceuticals IONS Stock Holding History

Schroder Investment Management Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Buy
+58,865
New +$4.43M ﹤0.01% 794
2025
Q3 		– Sell
-45,950
Closed -$1.82M – 1221
2025
Q2 		$1.82M Hold
45,950
– – ﹤0.01% 923
2025
Q1 		$1.43M Sell
45,950
-54,709
-54% -$1.79M ﹤0.01% 949
2024
Q4 		$3.52M Buy
100,659
+44,437
+79% +$1.66M ﹤0.01% 834
2024
Q3 		$2.3M Hold
56,222
– – ﹤0.01% 917
2024
Q2 		$2.68M Sell
56,222
-59,436
-51% -$2.44M ﹤0.01% 892
2024
Q1 		$5.01M Buy
115,658
+72,658
+169% +$3.46M 0.01% 780
2023
Q4 		$2.18M Buy
+43,000
New +$2.06M ﹤0.01% 893
2021
Q2 		– Sell
-589
Closed -$26K – 1561
2021
Q1 		$26K Sell
589
-240
-29% -$13.4K ﹤0.01% 1450
2020
Q4 		$47K Sell
829
-118
-12% -$5.88K ﹤0.01% 1394
2020
Q3 		$43K Sell
947
-325
-26% -$18.1K ﹤0.01% 1271
2020
Q2 		$75K Sell
1,272
-120
-9% -$6.67K ﹤0.01% 1168
2020
Q1 		$71K Buy
+1,392
New +$77.6K ﹤0.01% 1204
2019
Q4 		– Sell
-18,647
Closed -$1.1M – 1310
2019
Q3 		$1.1M Buy
+18,647
New +$1.22M ﹤0.01% 973
2019
Q2 		– Sell
-11,460
Closed -$930K – 1235
2019
Q1 		$930K Sell
11,460
-524
-4% -$33.8K ﹤0.01% 913
2018
Q4 		$648K Sell
11,984
-2,096
-15% -$107K ﹤0.01% 960
2018
Q3 		$726K Buy
+14,080
New +$662K ﹤0.01% 983
2017
Q4 		– Sell
-5,047
Closed -$266K – 1362
2017
Q3 		$266K Sell
5,047
-2,702
-35% -$142K ﹤0.01% 1164
2017
Q2 		$401K Buy
+7,749
New +$361K ﹤0.01% 1092

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Schroder Investment Management Group's IONS Position: Q2 2026 in Review

Schroder Investment Management Group opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 58,865 shares worth $4.75M. The stake represents ﹤0.01% of the portfolio and ranks #794 among its holdings. This is a return to the name: Schroder Investment Management Group previously reported a position in IONS as recently as Q2 2025.

Schroder Investment Management Group first reported a position in IONS in Q2 2017 and has held it in 19 quarters since. The position peaked at $5.01M in Q1 2024. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Schroder Investment Management Group held 58,865 shares of Ionis Pharmaceuticals worth $4.75M as of Q2 2026.
  • Ionis Pharmaceuticals was a new Schroder Investment Management Group position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #794 holding.
  • Schroder Investment Management Group first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 19 quarters since.
  • Schroder Investment Management Group's Ionis Pharmaceuticals position peaked at $5.01M in Q1 2024.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.